Assessing patients’ satisfaction with anti-TNFα treatment in Crohn’s disease: qualitative steps of the development of a new questionnaire

References

• StangeEFTravisSPVermeireSEuropean evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosisGut200655Suppl 1i1i1516481628
   PubMed Web of Science ®Google Scholar
• BaumgartDCThe diagnosis and treatment of Crohn’s disease and ulcerative colitisDtsch Arztebl Int200910612313319568370
   PubMed Web of Science ®Google Scholar
• TravisSPStangeEFLemannMEuropean evidence based consensus on the diagnosis and management of Crohn’s disease: current managementGut200655Suppl 1i16i3516481629
   PubMed Web of Science ®Google Scholar
• BehmBWBickstonSJTumor necrosis factor-alpha antibody for maintenance of remission in Crohn’s diseaseCochrane Database Syst Rev20081CD00689318254120
   PubMed Web of Science ®Google Scholar
• Peyrin-BirouletLDeltenrePdeSNEfficacy and safety of tumor necrosis factor antagonists in Crohn’s disease: meta-analysis of placebo-controlled trialsClin Gastroenterol Hepatol2008664465318550004
   PubMed Web of Science ®Google Scholar
• ClarkMColombelJFFeaganBCAmerican gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006Gastroenterology200713331233917631151
   PubMed Web of Science ®Google Scholar
• CasellasFRodrigoLNinoPSustained improvement of health-related quality of life in Crohn’s disease patients treated with infliximab and azathioprine for 4 yearsInflamm Bowel Dis2007131395140017567874
   PubMed Web of Science ®Google Scholar
• RutgeertsPSchreiberSFeaganBCertolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNF alpha, improves health-related quality of life in patients with moderate to severe Crohn’s diseaseInt J Colorectal Dis20082328929618071721
   PubMed Web of Science ®Google Scholar
• LoftusEVJrSchoenfeldPSandbornWJThe epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic reviewAliment Pharmacol Ther200216516011856078
   PubMed Web of Science ®Google Scholar
• PieperCHaagSGesenhuesSGuideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders – an evaluation studyBMC Health Serv Res200991719173739
   PubMed Web of Science ®Google Scholar
• WeaverMPatrickDLMarksonLEIssues in the measurement of satisfaction with treatmentAm J Manag Care1997357959410169526
   PubMed Web of Science ®Google Scholar
• SandbornWJFeaganBGHanauerSBA review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s diseaseGastroenterology200212251253011832465
   PubMed Web of Science ®Google Scholar
• VanderheydenLCVerhoefMJHilsdenRJQualitative research in inflammatory bowel disease: dispelling the myths of an unknown entityDig Liver Dis200638606316216567
   PubMedGoogle Scholar
• BernklevTJahnsenJAadlandEHealth-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosisScand J Gastroenterol20043936537315125469
   PubMed Web of Science ®Google Scholar
• BernklevTJahnsenJLygrenIHealth-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population normsInflamm Bowel Dis20051190991816189421
   PubMed Web of Science ®Google Scholar
• CohenRDThe quality of life in patients with Crohn’s diseaseAliment Pharmacol Ther2002161603160912197839
   PubMed Web of Science ®Google Scholar
• LoftusEVFeaganBGColombelJFEffects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn’s disease: patient-reported outcomes of the CHARM trialAm J Gastroenterol20081033132314118853973
   PubMed Web of Science ®Google Scholar
• Van AsscheGAVermeireSBalletVSwitch to Adalimumab in Patients With Crohn’s Disease Controlled by Maintenance Infliximabthe Prospective Randomized Switch Study. Digestive Disease Week2010 May 1New Orleans, USA
   Google Scholar
• OliverRLSatisfaction: A Behavioral Perspective on the ConsumerNew YorkMcGraw-Hill1997
   Google Scholar
• SchipperHGuidelines and caveats for quality of life measurement in clinical practice and researchOncology (Williston Park)1990451572143410
   PubMedGoogle Scholar
• ShikiarRRentzAMSatisfaction with medication: an overview of conceptual, methodologic, and regulatory issuesValue Health2004720421515164810
   PubMed Web of Science ®Google Scholar
• PallisAGMouzasIAInstruments for quality of life assessment in patients with inflammatory bowel diseaseDig Liver Dis20003268268811142577
   PubMedGoogle Scholar
• AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
   PubMedGoogle Scholar
• Food and Drug AdministrationGuidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. FDA website2009 Available online at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed July 16, 2010.
   Google Scholar
• SmithJAHarréRVan LangehoveLSemi-Structured Interviewing and Qualitative Analysis Rethinking Methods in PsychologyLondonSage Publications2009
   Google Scholar
• ChiltonFCollettRATreatment choices, preferences and decision-making by patients with rheumatoid arthritisMusculoskeletal Care2008611417726671
   PubMedGoogle Scholar
• KeiningerDCotteurGThe self-injection assessment questionnaire© (SIAQ©): Development and content validation10th Annual European Congress. International Society for Pharmacoeconomics and Outcomes Research2007 October 21Dublin
   Google Scholar
• KivitzACohenSDowdJEClinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trialClin Ther2006281619162917157117
   PubMed Web of Science ®Google Scholar
• CoyneKJoshua-GotlibSKimelMValidation of the treatment satisfaction questionnaire for Crohn’s disease (TSQ-C)Dig Dis Sci20055025225815745081
   PubMed Web of Science ®Google Scholar
• SadowskiDCBernsteinCNBittonACanadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s diseaseCan J Gastroenterol20092318520219319383
   PubMed Web of Science ®Google Scholar
• BaarsJESiegelCAKuipersEJPatient’s perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel diseaseDigestion200979303519246918
   PubMed Web of Science ®Google Scholar
• SiegelCALevyLCMackenzieTAPatient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel diseaseInflamm Bowel Dis2008141617924559
   PubMed Web of Science ®Google Scholar
• StraussACorbinJBasics of Qualitative Research: Techniques and Procedures for Developing Grounded TheoryLondonSage1998
   Google Scholar
• RuizMAPardoARejasJDevelopment and validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©Value Health20081191392618494753
   PubMed Web of Science ®Google Scholar
• Dunbar-JacobJErlenJASchlenkEAAdherence in chronic diseaseAnnu Rev Nurs Res200018489010918932
   PubMedGoogle Scholar
• HirshATAtchisonJWBergerJJPatient satisfaction with treatment for chronic pain: predictors and relationship to complianceClin J Pain20052130231015951647
   PubMed Web of Science ®Google Scholar
• WoodsideAGFreyLLDalyRTLinking service quality, customer satisfaction, and behavioral intentionJ Health Care Mark1989951710304174
   PubMedGoogle Scholar
• KumarRNKirkingDMHassSLThe association of consumer expectations, experiences and satisfaction with newly prescribed medicationsQual Life Res2007161127113617530445
   PubMed Web of Science ®Google Scholar
• AcquadroCJambonBEllisDLanguage and Translation IssuesSpilkerBQuality of Life and Pharmacoeconomics in Clinical TrialsPhiladelphiaLippincott-Raven Publishers1996575585
   Google Scholar